SEMA3G and systemic sclerosis: Thus, it is clear that further in-depth studies will be necessary to clarify the precise molecular mechanisms underlying the impairment of lymphangiogenesis in SSc, including possible abnormalities in the levels of anti-lymphangiogenic SEMA3F and SEMA3G.